linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth
ET Prime
Pharma

Clutching at straws, policymakers back hydroxychloroquine use in contagion battle. Safety, see you later.

Faced with a race against time, India’s top medical-research body has given the go-ahead to use hydroxychloroquine, an antiparasitic agent for malaria treatment, for prophylactic use among frontline healthcare workers. While physicians caution that this may be an ill-thought move, pharma manufacturers are sniffing opportunity.
font size
FONT SIZE
save
SAVE
saved
SAVED
Gift this article
GIFT ARTICLE
vikasdandekar1
26 Mar 2020 9 Mins Read 1 comments
Concept by Vikas Dandekar and Muhabit ul haq Shutterstock.com
Concept by Vikas Dandekar and Muhabit ul haq
This is one heck of a wily virus. Look at the games it can play. Some of those it infects won’t show symptoms and yet pass it on to others. When the immune system fights back, the virus can deceive it into overreacting, so that the body’s defence mechanism ends up doing more harm than the virus itself.
other large generic drug companies that are looking at stepping up production. For the drug derived from the bark of the cinchona tree found in Latin America, Covid-19 is a big test. If chloroquine and its cousin can pin down the wily coronavirus, it will be a milestone in medical history. ( Graphics by Mohammad Arshad)
This is one heck of a wily virus. Look at the games it can play. Some of those it infects won’t show symptoms and yet pass it on to others. When the immune system fights back, the virus can deceive it into overreacting, so that the body’s defence mechanism ends up doing more harm than the virus itself. other large generic drug companies that are looking at stepping up production. For the drug derived from the bark of the cinchona tree found in Latin America, Covid-19 is a big test. If chloroquine and its cousin can pin down the wily coronavirus, it will be a milestone in medical history. ( Graphics by Mohammad Arshad)

The latest from ET Prime is now on Telegram. To subscribe to our Telegram newsletter click here.

Gift this story

YOU CAN GIFT 0 MORE STORIES THIS MONTH

Maximum 10 Email IDs allowed

300 characters remaining

Gift Sent Successfully

Limit Reached
Limit Reached

You’ve gifted all the 0 articles from your monthly gift bucket!

Please come back next month.

0 more articles will be waiting for you in your gift bucket.

CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY

test

user Vikas Dandekar ET Prime, Editor - Pharma and Life Sciences

Current Edition

Stay on top with ET Prime's free reads on the viral outbreak
From our archives

Stay on top with ET Prime's free reads on the viral outbreak

Here you will find a curated collection from our relentless coverage on the outbreak and its implications, spanning across sectors and situations. As always, bringing together ET Prime's deep reportage and nuanaced analysis of issues, these stories will keep you up to date on what's unfolding and what's up next.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]